Sponsor:
UCLA
Code:
NCT04763980
Conditions
Prostate Carcinoma
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Educational Intervention
Genetic Testing
Survey Administration
ProGene Artificial Intelligence (AI) Platform
Interviews
Brief summary:
Conditions
Prostate Carcinoma
Study ID
NCT04763980
Start date
Jan 15, 2021
Status verified date
Dec, 2025
Completion date
Mar 31, 2027
Anticipated
Primary completion date
Mar 31, 2027
Anticipated
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
72 participants
Anticipated
Allocation
Non randomized
Intervention Model
Sequential
Primary purpose
Health Services Research
Arms
active comparator: CLOSED TO ENROLLMENT - Initial Pilot Cohort A (survey, genetic testing)
experimental: CLOSED TO ENROLLMENT -Initial Pilot Cohort B (educational session, survey, genetic testing)
experimental: Part 1 (educational session, survey, genetic testing)
experimental: Part 2 Pilot (educational session, survey, genetic testing)
Interventions
Educational Intervention
Genetic Testing
Survey Administration
ProGene Artificial Intelligence (AI) Platform
Interviews
Primary outcome measure
Central contacts
Locations
Zuckerberg San Francisco General Hospital
Recruiting
San Francisco, California, United States, 94110
Contacts
Miriam Perales
Miriam.Perales@ucsf.eduUniversity of California San Francisco
Recruiting
San Francisco, California, United States, 94143
Contacts
Principal Investigator:
Daniel Kwon, MD
Sponsor
University of California, San Francisco
Last update posted
Dec 31, 2025
Last verified
Dec, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2025-12-31.